Home › Melanoma › Rhode Island › Providence
Melanoma clinical trials in Providence, RI
4 studies for Melanoma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecruitingPhase 3
- Lifespan Cancer Institute, Providence
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Rhode Island Hospital, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecruitingPhase 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Providence
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN33 studies
- Pittsburgh, PA31 studies
- Boston, MA26 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Atlanta, GA21 studies
- Durham, NC21 studies
- St. Louis, MO21 studies
- Columbus, OH21 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Endometrial Cancer14 studies
- Obesity14 studies
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)12 studies
- Crohn's Disease12 studies
- Ulcerative Colitis11 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia10 studies
- Metastatic Cancer9 studies
- Overweight9 studies
- Alzheimer's Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.